Role of Rac1 GTPase in salt-sensitive hypertension

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 2, 2013, Pages 148-155

  Nagase, Miki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aldosterone; mineralocorticoid receptor; Na transporters; oxidative stress; Rac1

Indexed keywords

ALDOSTERONE RECEPTOR; ANGIOTENSIN II; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MINERALOCORTICOID RECEPTOR; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

BLOOD PRESSURE REGULATION; DAHL SALT SENSITIVE RAT; HEART DISEASE; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; LIGAND BINDING; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SALT INTAKE; SALT SENSITIVE HYPERTENSION; SODIUM ABSORPTION; SODIUM TRANSPORT;

ANIMALS; BLOOD PRESSURE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; HYPERTENSION; KIDNEY; LIGANDS; RAC1 GTP-BINDING PROTEIN; RATS; RATS, INBRED DAHL; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY;

EID: 84873557033     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32835d0751     Document Type: Review

References (80)

1. Fujita T, Henry WL, Bartter FC, et al. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980; 69:334-344.
2. Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321:580-585.
3. Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitivity of blood pressure in nondiabetic people in China: a dietary intervention study. Lancet 2009; 373:829-835.
4. Rapp JP, Wang SM, Dene H. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989; 243:542-544.
5. Deng Y, Rapp JP. Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nat Genet 1992; 1:267-272.
6. Cicila GT, Rapp JP, Wang JM, et al. Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet 1993; 3:346-353.
7. Deng AY, Dene H, Pravenec M, Rapp JP. Genetic mapping of two new blood pressure quantitative trait loci in the rat by genotyping endothelin system genes. J Clin Invest 1994; 93:2701-2709.
8. Makita K, Takahashi K, Karara A, et al. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 1994; 94:2414-2420.
9. Deng AY, Rapp JP. Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in the Dahl salt-sensitive rat. J Clin Invest 1995; 95:2170-2177.
10. Gu L, Dene H, Deng AY, et al. Genetic mapping of two blood pressure quantitative trait loci on rat chromosome 1. J Clin Invest 1996; 97:777-788.
11. Herrera VL, Xie HX, Lopez LV, et al. The alpha1 Na,K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitive HSD rat. J Clin Invest 1998; 102:1102-1111.
12. Nagase M, Ando K, Katafuchi T, et al. Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats. Hypertension 1997; 30:177-183.
13. Nagase M, Kaname S, Nagase T, et al. Expression of LOX-1, an oxidized lowdensity lipoprotein receptor, in experimental hypertensive glomerulosclerosis. J Am Soc Nephrol 2000; 11:1826-1836.
14. Nagase M, Kato A, Ono T, et al. Retrotransposons transcribed preferentially in proximal tubules of salt-hypertensive rats. Kidney Int 1999; 55:995-1004.
15. Choi M, Scholl UI, Yue P, et al. K\+ channel mutations in adrenal aldosteroneproducing adenomas and hereditary hypertension. Science 2011; 331:768-772.
16. Vasan RS, Evans JC, Larson MG, et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004; 351:33-41.
17. Makhanova N, Hagaman J, Kim HS, Smithies O. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension 2008; 51:134-140.
18. Doi M, Takahashi Y, Komatsu R, et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010; 16:67-74.
19. Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, et al. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 2010; 24:2454-2463.
20. McCurley A, Pires PW, Bender SB, et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 2012; 18:1429-1433.
21. Huang BS, Leenen FH. Mineralocorticoid actions in the brain and hypertension. Curr Hypertens Rep 2011; 13:214-220.
22. Nagase M, Shibata S, Yoshida S, et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006; 47:1084-1093.
23. Nagase M, Matsui H, Shibata S, et al. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 2007; 50:877-883.
24. Shibata S, Nagase M, Yoshida S, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14:1370-1376.
25. Shibata S, Mu S, Kawarazaki H, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptordependent pathway. J Clin Invest 2011; 121:3233-3243.
26. Kawarazaki W, Nagase M, Yoshida S, et al. Angiotensin II-and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. J Am Soc Nephrol 2012; 23:997-1007.
27. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001; 81:153-208.
28. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008; 9:690-701.
29. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4:181-189.
30. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005; 6:167-180.
31. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007; 129:865-877.
32. Mundel P, Reiser J. Proteinuria: an enzymatic disease of the podocyte? Kidney Int 2010; 77:571-580.
33. Tian D, Jacobo SM, Billing D, et al. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 2010; 3:ra77.
34. Wei C, Moeller CC, Altintas MM, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14:55-63.
35. Lu TC, He JC, Wang ZH, et al. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem 2008; 283:8173-8182.
36. Akilesh S, Suleiman H, Yu H, et al. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest 2011; 121:4127-4137.
37. Sussman MA, Welch S, Walker A, et al. Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Invest 2000; 105:875-886.
38. Adam O, Frost G, Custodis F, et al. Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 2007; 50:359-367.
39. Satoh M,Ogita H, Takeshita K, et al. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci USA 2006; 103:7432-7437.
40. Shen E, Li Y, Shan L, et al. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 2009; 58:2386-2395.
41. Sawada N, Kim HH, Moskowitz MA, Liao JK. Rac1 is a critical mediator of endothelium-derived neurotrophic activity. Sci Signal 2009; 2:ra10.
42. Harada N, Iimuro Y, Nitta T, et al. Inactivation of the small GTPase Rac1 protects the liver from ischemia/reperfusion injury in the rat. Surgery 2003; 134:480-491.
43. Vecchione C, Aretini A, Marino G, et al. Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circ Res 2006; 98:218-225.
44. Desire L, Bourdin J, Loiseau N, et al. RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J Biol Chem 2005; 280:37516-37525.
45. Montalvo-Ortiz BL, Castillo-Pichardo L, Hernandez E, et al. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. J Biol Chem 2012; 287:13228-13238.
46. Loirand G, Pacaud P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol 2010; 7:637-647.
47. Hassanain HH, Gregg D, Marcelo ML, et al. Hypertension caused by transgenic overexpression of Rac1. Antioxid Redox Signal 2007; 9:91-100.
48. Sawada N, Salomone S, Kim HH, et al. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res 2008; 103:360-368.
49. Zimmerman MC, Dunlay RP, Lazartigues E, et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95:532-539.
50. Nozoe M, Hirooka Y, Koga Y, et al. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension 2007; 50:62-68.
51. Sauzeau V, Sevilla MA, Montero MJ, Bustelo XR. The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells. J Clin Invest 2010; 120:315-330.
52. Sauzeau V, Sevilla MA, Rivas-Elena JV, et al. Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 2006; 12:841-845.
53. Guilluy C, Bregeon J, Toumaniantz G, et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 2010; 16:183-190.
54. Wirth A, Benyo Z, Lukasova M, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 2008; 14:64-68.
55. Tzima E, Del Pozo MA, Kiosses WB, et al. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J 2002; 21:6791-6800.
56. Kawashima T, Bao YC, Nomura Y, et al. Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J Cell Biol 2006; 175:937-946.
57. Wu X, Tu X, Joeng KS, et al. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008; 133:340-353.
58. Dahl LK, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res 1974; 40:94-101.
59. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science 1991; 252:1813-1816.
60. Iwai J, Knudsen KD, Dahl LK, Tassinari L. Effects of adrenalectomy on blood pressure in salt-fed, hypertension-prone rats. Failure of hypertension to develop in absence of evidence of adrenal cortical tissue. J Exp Med 1969; 129:663-678.
61. Farjah M, Roxas BP, Geenen DL, Danziger RS. Dietary salt regulates renal SGK1 abundance: relevance to salt sensitivity in the Dahl rat. Hypertension 2003; 41:874-878.
62. Aoi W, Niisato N, Sawabe Y, et al. Abnormal expression of ENaC and SGK1 mRNA induced by dietary sodium in Dahl salt-sensitively hypertensive rats. Cell Biol Int 2007; 31:1288-1291.
63. Luther JM, Luo P, Wang Z, et al. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney Int 2012; 82:643-651.
64. Usher MG, Duan SZ, Ivaschenko CY, et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 2010; 120:3350-3364.
65. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocorticoid receptors in human coronary artery smooth muscle cells. Circ Res 2005; 96:643-650.
66. Friis MB, Friborg CR, Schneider L, et al. Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts. J Physiol 2005; 567:427-443.
67. Uhlik MT, Abell AN, Johnson NL, et al. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol 2003; 5:1104-1110.
68. Karpushev AV, Levchenko V, Ilatovskaya DV, et al. Novel role of Rac1/WAVE signaling mechanism in regulation of the epithelial Na\+ channel. Hypertension 2011; 57:996-1002.
69. Takemura Y, Goodson P, Bao HF, et al. Rac1-mediated NADPH oxidase release of O2-regulates epithelial sodium channel activity in the alveolar epithelium. Am J Physiol Lung Cell Mol Physiol 2010; 298:L509-L520.
70. Silva GB, Garvin JL. Rac1 mediates NaCl-induced superoxide generation in the thick ascending limb. Am J Physiol Renal Physiol 2010; 298:F421-F425.
71. Manning RD Jr, Meng S, Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 2003; 179:243-250.
72. Li N, Yi FX, Spurrier JL, et al. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol 2002; 282:F1111-F1119.
73. Schreck C, O'Connor PM. NAD(P)H oxidase and renal epithelial ion transport. Am J Physiol Regul Integr Comp Physiol 2011; 300:R1023-R1029.
74. Kirchner KA. Greater loop chloride uptake contributes to blunted pressure natriuresis in Dahl salt sensitive rats. J Am Soc Nephrol 1990; 1:180-186.
75. Liu R, Juncos LA. GTPase-Rac enhances depolarization-induced superoxide production by the macula densa during tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol 2010; 298:R453-R458.
76. Zhang R, Harding P, Garvin JL, et al. Isoforms and functions of NAD(P)H oxidase at the macula densa. Hypertension 2009; 53:556-563.
77. Fu Y, Hall JE, Lu D, et al. Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors. Hypertension 2012; 59:599-606.
78. Rodriguez-Iturbe B. Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension. Clin Exp Nephrol 2010; 14:105-111.
79. Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate saltdependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15:545-552.
80. Sanlioglu S, Williams CM, Samavati L, et al. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem 2001; 276:30188-30198.